SCHEMBL18800557

SCHEMBL18800557

COc1ccc(-c2cncc(N)c2C(=N)N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 1/20 0.45
▸ PRSS2 P07478 1/20 0.45
▸ PRSS3 P35030 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ MAP4K4 O95819 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP11B1 P15538 1/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ NQO2 P16083 2/20 0.42
▸ CHEK2 O96017 1/20 0.41
▸ RPS6KA3 P51812 1/20 0.40
▸ MAPKAPK2 P49137 1/20 0.40
▸ PTGS2 P35354 2/20 0.40
▸ TP53 P04637 1/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800606 0.96 NQO2 (0.43) PRSS1PRSS2PRSS3MAPTMAP4K4
SCHEMBL18800626 0.86 SMN1; SMN2 (0.48) PRSS1PRSS2PRSS3MAPTCYP1A2
SCHEMBL18800867 0.85 BTK (0.50) PRSS1PRSS2PRSS3MAPTMAP4K4
SCHEMBL18800738 0.83 TDO2 (0.49) PRSS1PRSS2PRSS3MAPTCYP1A2
SCHEMBL18800739 0.83 MEN1 (0.39) PRSS1PRSS2PRSS3KMT2ARPS6KA3
SCHEMBL18800873 0.82 SCN5A (0.37) CYP11B1CYP11B2
SCHEMBL18800479 0.79 BTK (0.54) MAP4K4TSHR
SCHEMBL18800610 0.76 BTK (0.43) PRSS1PRSS2PRSS3MAPTMAP4K4
SCHEMBL18800598 0.75 KDM4E (0.51) PRSS1MAPTCYP1A2CYP3A4CYP2D6
SCHEMBL18800716 0.72 PRKCQ (0.37) PRSS1MAPTCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback